Evidence map›Paper›PMID 20598280›Full record

ArticleAmerican journal of human genetics2010

Spoiling the whole bunch: quality control aimed at preserving the integrity of high-throughput genotyping.

Anna Pluzhnikov, Jennifer E Below, Anuar Konkashbaev, Anna Tikhomirov, Emily Kistner-Griffin, Cheryl A Roe, Dan L Nicolae, Nancy J Cox

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Integrated Genomic and Transcriptomic Study RevealsCirculation. Genomic and precision medicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anna PluzhnikovDepartment of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Jennifer E Below
Anuar Konkashbaev
Anna Tikhomirov
Emily Kistner-Griffin
Cheryl A Roe
Dan L Nicolae
Nancy J Cox
University of Chicago · USMedical University of South Carolina · USSUNY Upstate Medical University · US

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Genetic Studies of Diabetic ComplicationsR01DK077489 · NIDDK · UNIVERSITY OF CHICAGO · PI COX, NANCY J · 2006 to 2008
$1.8M
Genome-wide Association Mapping of Metabolic, Lung and Cardiovascular PhenotypesU01HL084715 · NHLBI · UNIVERSITY OF CHICAGO · PI COX, NANCY J · 2006 to 2008
$836k
NHLBI NIH HHS U01 HL084715NIDDK NIH HHS P60 DK020595NIDDK NIH HHS P60 DK20595NIDDK NIH HHS R01 DK077489
6 · The paper itself

Abstract

False-positive or false-negative results attributable to undetected genotyping errors and confounding factors present a constant challenge for genome-wide association studies (GWAS) given the low signals associated with complex phenotypes and the noise associated with high-throughput genotyping. In the context of the genetics of kidneys in diabetes (GoKinD) study, we identify a source of error in genotype calling and demonstrate that a standard battery of quality-control (QC) measures is not sufficient to detect and/or correct it. We show that, if genotyping and calling are done by plate (batch), even a few DNA samples of marginally acceptable quality can profoundly alter the allele calls for other samples on the plate. In turn, this leads to significant differential bias in estimates of allele frequency between plates and, potentially, to false-positive associations, particularly when case and control samples are not sufficiently randomized to plates. This problem may become widespread as investigators tap into existing public databases for GWAS control samples. We describe how to detect and correct this bias by utilizing additional sources of information, including raw signal-intensity data.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 1Diabetic NephropathiesGenome-Wide Association StudyGenotypeHumansPolymorphism, Single NucleotideQuality Control

Identifiers

PMID20598280
PMCPMC2896766
OpenAlexW2009492801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.